Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 14Gastrointestinal 9Gynecologic 5Thoracic 3Genitourinary 2Dermatologic 2Other 1

Conditions

Lung Neoplasms 3Smoking Cessation 1Prostatic Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Motivational Interviewing × Thoracic × Clear all
NCT06912113 2026-02-20

The Effect of Motivational ınterviewing on ıntention to Quit Smoking in Lung Cancer Patients

University of Gaziantep

Phase NA Completed
42 enrolled
Thoracic

Lung Neoplasms, Smoking Cessation

NCT05354882 2023-05-09

DEFACTO2

Université Sorbonne Paris Nord

Phase NA Unknown
150 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT00580398 2018-10-12

Smoking Cessation Intervention for Thoracic Patients

Massachusetts General Hospital

Phase 1/2 Completed
49 enrolled 10 charts
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡